Robert Gunning

Comptroller/Controller/Auditor chez FRAZIER LIFESCIENCES ACQUISITION CORPORATION

55 ans

Health Technology

Consumer Services

Profil

Robert W.
Gunning is currently Principal Accounting Officer, VP & Controller at NewAmsterdam Pharma Co. NV since 2026.
Formerly, Mr. Gunning was Controller at Altimmune, Inc. in 2026 and Vice President-Finance & Controller at Y-mAbs Therapeutics, Inc. from 2022 to 2026.
Mr. Gunning completed undergraduate education at Pace University.

Postes actifs de Robert Gunning

Sociétés	Poste	Début
FRAZIER LIFESCIENCES ACQUISITION CORPORATION	Comptroller/Controller/Auditor	10/08/2026

Tous les postes actifs de Robert Gunning

Anciens postes connus de Robert Gunning

Sociétés	Poste	Fin
ALTIMMUNE, INC.	Comptroller/Controller/Auditor	01/07/2026
YMAS THER	Comptroller/Controller/Auditor	01/04/2026

Voir l'expérience en détail de Robert Gunning

Formation de Robert Gunning

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Robert Gunning

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Entreprise privées	4
Pace University Pace University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Y-mAbs Therapeutics, Inc. Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer	Health Technology
Altimmune, Inc. Altimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals	Health Technology
NewAmsterdam Pharma Co. NV NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases	Health Technology